The COVID-19 Pandemic – Products

Care Access Research has announced it is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.

Digital Science has announced a partnership with Zhipu.AI to conduct data challenges and collaborate in building a COVID-19 information portal.

Siemens Healthineers has announced the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes COVID-19.

Scientists on Standby is a portal enabling scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing.

BioData has announced its support for the global science community with the introduction of a new video conferencing service in its Labguru ELN platform, free of charge for all customers.

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

PCR Biosystems are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.

MicrosensDx has announced that the test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs has now been assessed for clinical performance

SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.